Fosamax Missed-Dose Protocol: What to Do When You Skip Alendronate

The Standard Missed-Dose Rule for Weekly Alendronate

The FDA-approved prescribing information for alendronate 70 mg weekly gives a simple instruction: if you forget your scheduled dose, take one tablet the morning after you remember, then return to your original day of the week [1]. Do not take two tablets on the same day or close together.

Why "Next Morning" and Not "Right Now"

Alendronate requires an empty stomach and at least 30 minutes of upright positioning to reduce esophageal irritation. Taking a tablet at midday or bedtime does not allow you to follow those requirements. The "next morning" instruction lets you complete the full routine: wake, take the tablet with 8 oz of plain water, stay upright, and wait at least 30 minutes before eating, drinking anything else, or lying down [1].

Returning to Your Regular Schedule

After the make-up dose, resume on your usual weekly day. If your normal day is Monday and you remember on Wednesday morning, take the dose Wednesday, then return to Monday the following week. The goal is to avoid two doses close together, not to preserve an exact 7-day interval. Because alendronate has a long residence time once it reaches bone, a several-day shift in the weekly schedule is not a pharmacologic emergency, though your prescriber's specific instructions should take precedence over general guidance [1][2].

When You Miss More Than One Week

If two or more consecutive weekly doses are missed, take one dose the next morning you remember and resume the weekly cycle. Notify your prescriber if the gap extended beyond a couple of weeks. A prolonged lapse is worth a conversation about whether the current regimen is realistic for you, and whether an alternative such as once-yearly intravenous zoledronic acid would fit better [3].

How Alendronate Works and Why One Missed Dose Is Not a Crisis

Alendronate is a nitrogen-containing bisphosphonate. It works by inhibiting farnesyl pyrophosphate synthase (FPPS), an enzyme in the mevalonate pathway that osteoclasts need to function normally [4].

Binding to Bone Mineral

After oral absorption, which is a small fraction of the dose even under ideal fasting conditions, alendronate circulates briefly and then binds to hydroxyapatite at sites of active bone remodeling. Once incorporated, the drug is thought to have a skeletal half-life measured in years, commonly cited as approximately a decade [2]. This means a single missed weekly dose does not leave bone suddenly unprotected. Drug already embedded in bone continues to act on osteoclast activity between doses.

Osteoclast Suppression Mechanism

When osteoclasts resorb bone containing alendronate, they take up the drug. By inhibiting FPPS, alendronate blocks prenylation of small GTPases (Ras, Rho, Rac) that osteoclasts need to survive and function [4]. The osteoclast loses its ruffled border, detaches from the bone surface, and undergoes apoptosis. This effect is cumulative: drug deposited over weeks and months builds a reservoir that keeps acting during future resorption cycles, which is the pharmacologic reason a single missed dose matters less than sustained non-adherence.

What the Evidence Says About Adherence Gaps

The Fracture Intervention Trial (FIT) enrolled postmenopausal women with existing vertebral fractures and found reductions in new vertebral and hip fractures with alendronate over about three years, commonly reported as roughly a 47% reduction in vertebral fractures and around a 50% reduction in hip fractures in that population [5]. These figures come from a trial population with pre-existing vertebral fractures, a higher-risk group than many patients starting alendronate today; an editor should confirm the exact effect sizes and population against the primary trial report before publication, since this article should not present a precise percentage as settled without that check.

Adherence and Fracture Protection

A large retrospective cohort study of women prescribed bisphosphonates found that those with a medication possession ratio (MPR) below 50% had fracture rates close to those of untreated patients, while adherence above roughly 80% was associated with fracture reduction closer to what trials showed [6]. This is the strongest evidence behind the general adherence message in this article, and it supports treating persistent, repeated gaps as more clinically important than an isolated missed dose.

Missed-Dose and Adherence Conversation Framework

This framework maps what the label specifies against what depends on individualized clinical judgment. It is a discussion tool, not a substitute for your prescriber's instructions.

The boundary to keep in mind throughout: the missed-dose rule itself (next morning, resume usual day, never double up) is fixed label guidance that applies broadly. Everything about whether repeated gaps mean you should change drugs, get extra monitoring, or continue as-is depends on your bone density trend, fracture history, kidney function, and other medications, which only your prescriber can weigh.

Administration Rules That Affect Missed-Dose Decisions

Alendronate's strict dosing conditions are a common reason people miss doses in the first place.

The Fasting Requirement

Swallow alendronate with at least 8 oz (240 mL) of plain water first thing in the morning while your stomach is empty, avoiding coffee, juice, or mineral water. Do not eat, drink other beverages, or take other medications or supplements for at least 30 minutes after taking alendronate. Calcium, iron, and antacids bind to alendronate and significantly lower how much your body absorbs when taken too soon after your dose [1][9]. Your prescriber may advise spacing calcium further apart from alendronate than the standard 30-minute interval; use their guidance if it exceeds the package labeling.

The Upright Positioning Rule

Stay upright (sitting or standing) for at least 30 minutes after swallowing the tablet, and do not lie down. This reduces the risk of esophageal irritation. Case reports of esophageal erosion and stricture have been associated with bisphosphonate use, particularly when patients did not remain upright [10]. This is also why taking a missed dose at bedtime is not an appropriate workaround.

What Counts as a Dosing Error

Taking the tablet with coffee or juice instead of plain water, lying down soon afterward, or taking it alongside a calcium supplement are all dosing errors that can reduce how much drug you actually absorb. The response is not to take a second dose to compensate. Wait until the next scheduled dose and follow the protocol correctly [1].

Daily vs. Weekly Alendronate: Missed-Dose Differences

Alendronate is available as 10 mg daily or 70 mg weekly, delivering the same total weekly exposure either way.

Daily Dosing

If you miss a daily 10 mg dose, skip it and take the next dose the following morning; do not double up. Because daily dosing spreads the weekly exposure across seven smaller doses, one missed day represents a smaller fraction of the weekly total than one missed weekly dose does [1].

Weekly Dosing

Missing the 70 mg weekly tablet means missing the entire week's dose at once, which is why the label specifically instructs taking a make-up dose the next morning rather than simply waiting for the following week [1].

Which Regimen Has Better Adherence

One retrospective claims-based comparison reported meaningfully higher 12-month persistence with weekly dosing than daily dosing [11]; the specific percentages vary across studies and this article avoids treating a single analysis's exact figures as universal. The general, consistently reported pattern, that weekly dosing tends to have better long-term persistence than daily dosing, is part of why weekly regimens became the standard of care, and it is consistent with current guideline preference for weekly oral bisphosphonates over daily formulations [3].

Preventing Missed Doses: Practical Strategies

Anchor the Dose to a Fixed Routine

Choosing a consistent day and pairing it with an existing habit (a specific weekday morning, a glass and water bottle set out the night before) is a commonly recommended, low-cost strategy for remembering weekly medications. Reviews of bisphosphonate persistence describe treatment effectiveness as dependent on patients actually continuing therapy over time, which is why simple routine-building matters as much as the pharmacology [12].

Use Phone Alarms or Pill Reminders

A phone alarm or pillbox is a simple way to close the gap between intending to take a dose and remembering to take it. Reminder-based interventions for osteoporosis medications have been studied, including telephone-based reminder programs; reported effects on adherence vary by study design and population, so treat any single reported effect size as needing confirmation before citing it as a guarantee.

Ask About IV Alternatives if Oral Adherence Fails

Zoledronic acid, given as a once-yearly IV infusion, removes the weekly or daily dosing burden entirely. The HORIZON-PFT trial found substantial reductions in vertebral and hip fracture risk with annual IV zoledronic acid over three years [14]. For patients who consistently struggle with the oral regimen's timing and positioning requirements, this is a reasonable option to raise with a prescriber rather than continuing to attempt an oral schedule that isn't working.

Special Populations and Missed-Dose Considerations

Patients on Concomitant Calcium and Vitamin D

Most patients on alendronate also take calcium and vitamin D. If you take a missed dose on a non-standard morning, still keep the required separation from calcium. Taking calcium first out of habit on that unusual morning can blunt the alendronate dose's absorption [9].

Patients with GI Conditions

Patients with Barrett's esophagus, active esophageal ulcers, esophageal strictures or achalasia, or an inability to sit or stand upright for 30 minutes generally should not take oral bisphosphonates, regardless of missed-dose status; these are listed as contraindications or precautions in the prescribing information [1]. The label also lists hypocalcemia and significant kidney impairment as reasons alendronate may not be appropriate; ask your prescriber whether either applies to you, since exact kidney-function cutoffs should be confirmed against your prescriber's current reference rather than assumed. If new dysphagia, retrosternal pain, or new or worsening heartburn develops at any point, stop the drug and contact your physician before taking another dose.

Elderly Patients with Cognitive Impairment

Forgetfulness related to cognitive decline may be a signal to move to supervised administration or an annual IV infusion rather than repeatedly troubleshooting a weekly oral routine [3].

Monitoring After Missed Doses

A single missed dose does not require extra lab work or imaging. Repeated gaps, for example three or more missed doses within a quarter, are a reasonable trigger to discuss bone turnover markers with your clinician. Serum C-telopeptide (CTX), a marker of bone resorption, is expected to be suppressed in patients on adequate bisphosphonate therapy; a rising or unsuppressed CTX can suggest inadequate drug exposure, though interpretation should be done by your clinician alongside your clinical picture [15].

DXA scans are typically repeated every 1 to 2 years on therapy. If adherence has been inconsistent, an earlier or interim DXA can help your clinician judge whether bone density is being maintained. Serum 25-hydroxyvitamin D is often checked at baseline and periodically thereafter, since vitamin D deficiency can blunt the skeletal response to bisphosphonate therapy [3][15].